Real-World Impact of Empagliflozin on Total Cost of Care in Adults with Type 2 Diabetes: Results from An Outcomes-Based Agreement

Peasah S, Huang Y, Palli S, Swart ECS, Donato B, Pimple P, Bovier J, Manolis C, Good CB. Real-World Impact of Empagliflozin on Total Cost of Care in Adults with Type 2 Diabetes: Results from an Outcomes-Based Agreement. J Manag Care Spec Pharm; 27 January 2023;29(2):152-160. https://doi.org/10.18553/jmcp.2023.29.2.152